Concepedia

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

Vianney Tricou, Xavier Sáez‐Llorens, Delia Yu, Luis Rivera, José Jimeno, Ana Cecilia Villarreal, Epiphany Dato, Onix Saldaña de Suman, Nathali Montenegro, Rodrigo DeAntonio,

The Lancet · 2020 · 105 citations · 15 references

DOI

Concepts

References

15

The global distribution and burden of dengue

Samir Bhatt, Peter W. Gething, Oliver J. Brady et al. · Nature · 2013 · 10.2K citations · Full text

, , +12

Antibody-dependent enhancement of severe dengue disease in humans

Leah C. Katzelnick, Lionel Gresh, M. Elizabeth Halloran et al. · Science · 2017 · 1.2K citations · Full text

, , +17

Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy

Saranya Sridhar, Alexander R. Luedtke, Edith Langevin et al. · New England Journal of Medicine · 2018 · 789 citations · Full text

, , +16

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Shibadas Biswal, Humberto Reynales, Xavier Sáez‐Llorens et al. · New England Journal of Medicine · 2019 · 389 citations · Full text

, , +17

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Shibadas Biswal, Suely Tuboi, Vianney Tricou · The Lancet · 2020 · 250 citations · Full text

, , +16